Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Gr xdc nenthal Gmbh patents


Recent patent applications related to Gr xdc nenthal Gmbh. Gr xdc nenthal Gmbh is listed as an Agent/Assignee. Note: Gr xdc nenthal Gmbh may have other listings under different names/spellings. We're not affiliated with Gr xdc nenthal Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gr xdc nenthal Gmbh-related inventors


 new patent  Tamper resistant formulation of ephedrine and its derivatives

A pharmaceutical dosage form having a breaking strength of at least 300 N and comprising an ephedrine component selected from the group consisting of ephedrine, pseudoephedrine and the physiologically acceptable salts thereof, wherein the weight content of the ephedrine component is within the range of from 0.1 to 60 wt.-%,... Gr xdc nenthal Gmbh

 new patent  Crystalline salts of hydrocodone bitartrate

Crystalline salts of 4,5 α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) (hydrocodone bitartrate) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a pharmaceutical composition comprising such a salt and such a salt as a medicament and for the treatment and/or prevention of pain.... Gr xdc nenthal Gmbh

Tamper-resistant dosage form comprising a polyethylene glycol graft copolymer

A tamper-resistant, oral pharmaceutical dosage form comprising a pharmacologically active ingredient having psychotropic action and a polyethylene glycol graft copolymer, wherein the content of the polyethylene glycol graft copolymer is at least 25 wt.-%, relative to the total weight of the pharmaceutical dosage form. Also disclosed is the manufacture of... Gr xdc nenthal Gmbh

Tamper resistant dosage form with bimodal release profile

wherein the at least one formed segment (S1) exhibits a higher breaking strength than the at least one further segment (S2) and the at least one formed segment (S1) exhibits a breaking strength of more than 500 N.... Gr xdc nenthal Gmbh

Modified release abuse deterrent dosage forms

The invention relates to a pharmaceutical dosage form for oral administration comprising a pharmacologically active compound; wherein a portion of said pharmacologically active compound is contained in a multitude of immediate release particles providing immediate release of the pharmacologically active compound; wherein another portion of said pharmacologically active compound is... Gr xdc nenthal Gmbh

Treatment and/or prophylaxis of tspo mediated diseases and/or disorders

The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.... Gr xdc nenthal Gmbh

Abuse-proofed dosage form

A solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active substances that have parenteral abuse potential. The agent forms, when a necessary minimum amount of an aqueous liquid is added, on the basis of an extract obtained from... Gr xdc nenthal Gmbh

Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol

The present invention relates to a process for the preparation of (1R,2R)-3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol.... Gr xdc nenthal Gmbh

Abuse-proofed oral dosage form

... Gr xdc nenthal Gmbh

Abuse-proofed dosage form

The invention relates to a dosage form that is thermoformed without discoloration and is safeguarded from abuse, comprising at least one synthetic or natural polymer having a breaking strength of at least 500 N in addition to one or more active substances that could be subject to abuse. The invention... Gr xdc nenthal Gmbh

Pharmaceutical salts

The invention relates to pharmaceutical salts comprised of a pharmaceutical active substance and of at least one sugar substitute, to medicaments containing these salts, and to the use of these salts for producing medicaments.... Gr xdc nenthal Gmbh

Heteroaryl substituted heterocyclyl sulfones

The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.... Gr xdc nenthal Gmbh

Tamper-resistant dosage form with immediate release and resistance against solvent extraction

A tamper-resistant pharmaceutical dosage form comprising a multitude of particles which comprise a pharmacologically active compound, a polyalkylene oxide, and a disintegrant; wherein the pharmacologically active compound is dispersed in a matrix comprising the polyalkylene oxide and the disintegrant; wherein the content of the disintegrant is more than 5.0 wt.-%,... Gr xdc nenthal Gmbh

Pyrazolyl substituted tetrahydropyranylsulfones

The invention relates to pyrazolyl substituted tetrahydropyranylsulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.... Gr xdc nenthal Gmbh

Pyrazolyl substituted tetrahydropyranylsulfones

The invention relates to pyrazolyl substituted tetrahydropyranylsulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.... Gr xdc nenthal Gmbh

Protecting oral overdose with abuse deterrent immediate release formulations

The invention relates to a pharmaceutical dosage form which is particularly useful for the prevention of an overdose of the pharmacologically active ingredient contained therein after accidental or intentional simultaneous administration of a plurality of the dosage forms containing an overall supratherapeutic dose of the pharmacologically active ingredient.... Gr xdc nenthal Gmbh

Abuse-proofed dosage form

The present invention relates to an abuse-proofed, thermoformed dosage form containing, in addition to one or more active ingredients with abuse potential optionally together with physiologically acceptable auxiliary substances, at least one synthetic or natural polymer with a breaking strength of at least 500 N and to a process for... Gr xdc nenthal Gmbh








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gr xdc nenthal Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gr xdc nenthal Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###